Immatics (IMTX) Non-Current Deffered Revenue (2019 - 2025)

Immatics' (IMTX) quarterly Non-Current Deffered Revenue came in at $21.6 million in Q4 2025, down 40.88% year-on-year from $36.5 million in Q4 2024, and down 40.88% quarter-over-quarter from $36.5 million in Q4 2024.

Immatics (IMTX) Non-Current Deffered Revenue (2019 - 2025) Analysis & Trends

Immatics has disclosed Non-Current Deffered Revenue across 7 years of filings, most recently posting $21.6 million for Q4 2025.

  • Non-Current Deffered Revenue for Q4 2025 came in at $21.6 million, down 40.88% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.6 million (down 40.88% YoY), and the FY2025 annual result was $20.9 million, down 42.62% from the prior year.
  • Non-Current Deffered Revenue came in at $21.6 million for Q4 2025 at Immatics, down from $36.5 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $124.3 million in Q4 2023 to a low of $21.6 million in Q4 2025.
  • The 5-year median for Non-Current Deffered Revenue is $55.2 million (2021), against an average of $63.0 million.
  • Across the five-year window, Non-Current Deffered Revenue surged 60.82% in 2023 and plunged 70.63% in 2024, its largest moves.
  • Immatics' Non-Current Deffered Revenue stood at $55.2 million in 2021, then jumped by 40.1% to $77.3 million in 2022, then soared by 60.82% to $124.3 million in 2023, then sank by 70.63% to $36.5 million in 2024, then plunged by 40.88% to $21.6 million in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $21.6 million (Q4 2025), $36.5 million (Q4 2024), and $124.3 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immatics 14.67 Bn 14.67 Bn - 21.58 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 21.58 Mn
Dec 31, 2024 36.50 Mn
Dec 31, 2023 124.30 Mn
Dec 31, 2022 77.29 Mn
Dec 31, 2021 55.17 Mn
Dec 31, 2020 101.91 Mn
Dec 31, 2019 94.61 Mn